A detailed history of Pathway Financial Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Pathway Financial Advisors LLC holds 671 shares of AMGN stock, worth $212,036. This represents 0.06% of its overall portfolio holdings.

Number of Shares
671
Previous 671 -0.0%
Holding current value
$212,036
Previous $209,000 3.35%
% of portfolio
0.06%
Previous 0.06%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

BUY
$262.75 - $319.31 $176,305 - $214,257
671 New
671 $209,000
Q3 2022

Nov 04, 2022

BUY
$224.46 - $253.15 $72,725 - $82,020
324 Added 20.81%
1,881 $424,000
Q2 2022

Jul 21, 2022

BUY
$230.71 - $256.74 $359,215 - $399,744
1,557 New
1,557 $379,000
Q3 2018

Jan 16, 2019

SELL
$185.29 - $208.89 $105,800 - $119,276
-571 Closed
0 $0
Q1 2018

May 04, 2018

SELL
$169.43 - $198.0 $5,760 - $6,732
-34 Reduced 5.62%
571 $97,000
Q4 2017

May 04, 2018

BUY
$168.79 - $188.59 $102,117 - $114,096
605
605 $105,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Pathway Financial Advisors LLC Portfolio

Follow Pathway Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathway Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathway Financial Advisors LLC with notifications on news.